Clinical Trial Update: Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing amrubicin with or without cisplatin to etoposide-cisplatin for extensive-stage small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Amrubicin (amrubicin)
• CISPLATIN (cisplatin)
• etoposide/cisplatin

Snippet

Sponsor: Celgene | Conditions: Small Cell Lung Cancer | Phase 2 | Status: COMPLETED